Himisha Beltran, MD of Dana Farber @DanaFarber discusses circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer. How do we identify a subgroup of patients?
Read here: https://www.jci.org/articles/view/131041
Advertisement